Clinical Trial Update: Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the safety and efficacy of canakinumab prefilled syringes in patients with frequently flaring acute gouty arthritis; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• ILARIS (canakinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Gouty Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-01-29